Getting screened for cancer is smart. Yearly mammograms for women older than 40, prostate exams for men older than 50, and skin cancer screenings for just about everyone are just a few of the recommended measures individuals can take to ensure cancer stays away -- or at least is caught in its earliest forms.

But aside from merely submitting to these screenings, there's something we can do to increase our screening smarts. We can stick with the same screening centers and not flip-flop from one location to another.

It's a bad idea to report to a different screening center every year. Being able to compare a current mammogram, for example, with prior images can decrease false alarms by as much as 44 percent. As with much of life, consistency is key. Think about it. When we find that perfect hairstylist, we're sold -- and heartbroken when he or she moves on and we have to start from scratch. A trustworthy car mechanic who knows our car inside and out? Don't dare let him leave town. The most loving child care facility? The search is over, and we pray our kids don't get kicked out. Screening is no different really. So make this your mission: find a good thing and don't stray. Of course, don't linger at locations that make you uncomfortable for any reason. Search until you find happiness. Then stay put.

Source: Woman's Day, May 8, 2007

Eli Lilly and Company has launched a major clinical trial evaluating ALIMTA (pemetrexed for injection) in extensive stage small cell lung cancer (SCLC), a devastating and rapidly spreading form of lung cancer. SCLC is sometimes called oat cell cancer because small cell lung cancer cells resemble oat grains. Patients with SCLC are staged according to a two-stage system, being diagnosed as having either limited stage disease or extensive stage disease. About 65 to 70 percent of patients with SCLC are diagnosed with extensive stage disease and the current two year survival rate is less than 10 percent.

The GALES trial, Global Analysis of Pemetexed in SCLC Extensive Stage, is a Phase III trial that will enroll 1,820 patients with extensive stage disease. The study's primary objective is to compare the overall survival after treatment with pemetrexed plus carboplatin verses the current standard treatment of etoposide plus carboplatin.

More details on the study design and information on global recruitment sites may be found at www.clinicaltrials.gov and www.lillytrials.com or by calling 1-877-CTLILLY.

Decide what you want, decide what you are willing to exchange for it. Establish your priorities. And go to work. - H.L. Hunt

NutritionData Nutrition Facts & Calorie Counter offers a comprehensive common sense approach to successful weight loss from experts in nutrition and fitness for those interested in losing weight. Following is the information provided by NutritionData.

• The 2 Most Important Facts about Successful Weight Loss
• The 6 Most Important Principles for Enabling Weight Loss
• The Best Way to Satisfy Your Hunger Without Overeating
• The Best Nutritional Supplements for Weight Loss
• The Best Exercises for Weight Loss
• The Best Way to Monitor Your Weight Loss Progress
• The Best Thing to Do if Your Diet Fails
• Summary of Weight Loss Secrets
• Where to Get Additional Weight Loss Help

The Secrets of Weight Loss is one area within the NutritionData website -- and it is a fantastic destination for anything and everything you might want to know about food and nutrition. At NutritionData you can analyze any food, compare multiple foods, find foods that match specific criteria, learn more about nutrition and dieting, estimate your daily needs, track your total consumption, analyze and improve your recipes, generate custom nutrition facts labels, read about the 50 most popular foods and learn fast food facts.

Warning: You will spend much more time there than you planned -- reading about nutrition, the better choices diet, the fullness factor and comparing foods -- as these are just a few of the sections within this website. Seriously, this place is deep and rich in content.